Stay updated with breaking news from Pascal Touchon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) in a research note published on Thursday morning. The firm issued a sell rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and set a $28.00 price target on shares of Atara Biotherapeutics in a research note on Tuesday, […]
Company hopes for approval of drug to treat blood cancer.
HC Wainwright restated their buy rating on shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. The firm currently has a $28.00 target price on the biotechnology company’s stock. Separately, StockNews.com began coverage on shares of Atara Biotherapeutics in a report on Thursday, August […]
The latest people news happenings over the past month.
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Aug 8, 2023--